- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/38 - 2-Pyrrolones
Patent holdings for IPC class C07D 207/38
Total number of patents in this class: 174
10-year publication summary
|
5
|
10
|
10
|
11
|
3
|
12
|
15
|
7
|
8
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10163 |
10 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 177 |
7 |
| The University of British Columbia | 1567 |
7 |
| The University of Queensland | 651 |
7 |
| Conopco, Inc. | 5152 |
6 |
| Bayer Cropscience AG | 1817 |
6 |
| British Columbia Cancer Agency Branch | 177 |
6 |
| Bristol-myers Squibb Company | 4756 |
5 |
| Unilever PLC | 2965 |
5 |
| Ottawa Hospital Research Institute | 114 |
5 |
| University of Ottawa | 244 |
5 |
| Unilever N.V. | 2879 |
4 |
| Syngenta Participations AG | 1472 |
4 |
| Vectus Biosystems Limited | 28 |
3 |
| Beijing Joekai Biotech. LLC | 5 |
3 |
| Bilix Co., Ltd. | 21 |
3 |
| Huscion Co., Ltd. | 10 |
3 |
| Boehringer Ingelheim International GmbH | 4490 |
2 |
| Syngenta Limited | 419 |
2 |
| Bayer Intellectual Property GmbH | 2338 |
2 |
| Other owners | 79 |